According to the Zhitong Finance App, Xinguang Pharmaceutical (300519.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 143 million yuan, an increase of 1.17% over the previous year. Achieved net profit of 397.121 million yuan attributable to shareholders of listed companies, an increase of 24.46% over the previous year. Achieved net profit of 36.2094 million yuan after deducting non-recurring profit and loss attributable to shareholders of listed companies, an increase of 23.00% over the previous year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.